MET inhibition radiosensitizes KRAS-mutant rectal cancer.

被引：0

作者：

D'Ambrosio, Antonio ^{[1
]}

Verginelli, Federica ^{[1
]}

Orzan, Francesca ^{[1
]}

Albano, Raffaella ^{[1
]}

Casanova, Elena ^{[1
]}

Luraghi, Paolo ^{[1
]}

De Bacco, Francesca ^{[1
]}

Bertotti, Andrea ^{[2
]}

Trusolino, Livio ^{[2
]}

Senetta, Rebecca ^{[3
]}

Sapino, Anna ^{[3
]}

Del Mastro, Elena ^{[4
]}

Gatti, Marco ^{[4
]}

Comoglio, Paolo M. ^{[5
]}

Boccaccio, Carla ^{[1
]}

机构：

[1] IRCCS Candiolo Canc Inst, Lab Canc Stem Cell Res FPO, Candiolo, Italy

[2] IRCCS Candiolo Canc Inst, Lab Translat Canc Med FPO, Candiolo, Italy

[3] IRCCS Candiolo Canc Inst, Unit Pathol FPO, Candiolo, Italy

[4] IRCCS Candiolo Canc Inst, Unit Radiotherapy FPO, Candiolo, Italy

[5] IRCCS Candiolo Canc Inst, Lab Exploratory Res & Mol Canc Therapy FPO, Candiolo, Italy

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1387

引用

页数：2

共 50 条

[21] Hope for targeted treatment of KRAS-mutant lung cancer
Crisp, Alisa
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 121 - 121
[22] Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer.
Arbour, Kathryn Cecilia
Ricciuti, Biagio
Rizvi, Hira
Hellmann, Matthew D.
Yu, Helena Alexandra
Ladanyi, Marc
Kris, Mark G.
Arcila, Maria E.
Rudin, Charles M.
Lito, Piro
Awad, Mark M.
Riely, Gregory J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[23] Treating KRAS-Mutant Lung Cancer With Combination Agents
Shumeyko, Emma P.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (04) : 315 - 315
[24] Development of siRNA Payloads to Target KRAS-Mutant Cancer
Yuan, Tina L.
Fellmann, Christof
Lee, Chih-Shia
Ritchie, Cayde D.
Thapar, Vishal
Lee, Liam G.
Hsu, Dennis J.
Grace, Danielle
Carver, Joseph O.
Zuber, Johannes
Luo, Ji
McCormick, Frank
Lowe, Scott W.
CANCER DISCOVERY, 2014, 4 (10) : 1182 - 1197
[25] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Xiufeng Pang
Mingyao Liu
Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
[26] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Pang, Xiufeng
Liu, Mingyao
CHINESE JOURNAL OF CANCER, 2016, 35 : 92
[27] Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner
Georgios Vlachogiannis
Alexis De Haven Brandon
Melanie Valenti
Gary Box
Liam Jenkins
Caterina Mancusi
Annette Self
Floriana Manodoro
Ioannis Assiotis
Penny Robinson
Ritika Chauhan
Alistair G. Rust
Nik Matthews
Kate Eason
Khurum Khan
Naureen Starling
David Cunningham
Anguraj Sadanandam
Clare M. Isacke
Vladimir Kirkin
Nicola Valeri
Steven R. Whittaker
Oncogene, 2019, 38 : 1717 - 1733
[28] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
Cox, Adrienne D.
Goodwin, Craig M.
Bryant, Kirsten L.
Dagliyan, Irem
George, Samuel D.
Lucas, Kelly E.
Gautam, Prson
Wennerberg, Krister
Der, Channing J.
CANCER RESEARCH, 2018, 78 (13)
[29] Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Wagner, Steve
Vlachogiannis, Georgios
Brandon, Alexis De Haven
Valenti, Melanie
Box, Gary
Jenkins, Liam
Mancusi, Caterina
Self, Annette
Manodoro, Floriana
Assiotis, Ioannis
Robinson, Penny
Chauhan, Ritika
Rust, Alistair G.
Matthews, Nik
Eason, Kate
Khan, Khurum
Starling, Naureen
Cunningham, David
Sadanandam, Anguraj
Isacke, Clare M.
Kirkin, Vladimir
Valeri, Nicola
Whittaker, Steven R.
ONCOGENE, 2019, 38 (10) : 1717 - 1733
[30] Suppression of inflammatory gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Wagner, Steve
Vlachogiannis, George
Brandon, Alexis de Haven
Valenti, Melanie
Box, Gary
Jenkins, Liam
Mancusi, Caterina
Self, Annette
Chauhan, Ritika
Rust, Alistair
Matthews, Nik
Eason, Kate
Sadanandam, Anguraj
Isacke, Clare
Kirkin, Vladimir
Valeri, Nicola
Whittaker, Steven R.
CANCER RESEARCH, 2018, 78 (13)

← 1 2 3 4 5 →